ArriVent BioPharma Inc

NAS:AVBPHealthcareCBOEFTSE:MRUTNASDAQ:NBI

——At close · Market cap — · Next earnings Mon 9 Nov

Open-market trades from Form 4 filings

Insiders bought $0 and sold $12.98M in the filings shown.

Date	Name	Role	Type	Shares	Value
Wed, 10 Dec 2025	HHLR ADVISORS, LTD.	10 percent owner	S-Sale	555,555	$12.98M

From 13F filings · Tue, 30 Jun 2026

Holder	Shares	% out	Change
MONTANOVA CAPITAL, LLC	4,515,531	9.2%	+114,448
INFINITUM ASSET MANAGEMENT, LLC	4,438,384	9.0%	+289,461
HHLR ADVISORS, LTD.	3,929,117	8.0%	+0
BlackRock, Inc.	3,250,396	6.6%	+720,095
ORBIMED ADVISORS LLC	3,027,328	6.1%	+0
FMR LLC	2,778,959	5.6%	−237,173
Octagon Capital Advisors LP	1,971,054	4.0%	+0
VANGUARD CAPITAL MANAGEMENT LLC	1,774,873	3.6%	+245,980
Sofinnova Investments, Inc.	1,696,752	3.4%	+0
STATE STREET CORP	1,692,986	3.4%	+271,571
Vivo Capital, LLC	1,682,097	3.4%	+796,181
NOVO HOLDINGS A/S	1,500,000	3.0%	−442,142
General Catalyst Group Management, LLC	1,494,786	3.0%	+0
Logos Global Management LP	1,000,000	2.0%	+650,000
GEODE CAPITAL MANAGEMENT, LLC	972,626	2.0%	+168,974

Float 37,004,414 · outstanding 49,307,728